In Collaboration with
Supporting Organization
Venue : Island Ballroom, Level 5, Island Shangri-La, Hong Kong
Pacific Place, Supreme Court Road, Central, Hong Kong
Date & Time : 19th January 2019, 09:00 - 16:30
20th January 2019, 09:00 - 13:30
In Collaboration with
Supporting Organization
Venue : Island Ballroom, Level 5, Island Shangri-La, Hong Kong
Pacific Place, Supreme Court Road, Central, Hong Kong
Date & Time : 19th January 2019, 09:00 - 16:30
20th January 2019, 09:00 - 13:30
Message from HKSUO

Founded in July 2015, the Hong Kong Society of Uro-Oncology was established as a platform for specialist disciplines to collaborate in the management and treatment of urological cancers. In four years the Society has played a significant role in advancing the understanding and application of cutting edge treatments that has allowed doctors and medical practitioners in Hong Kong to make decisions that save lives.

The HKSUO has also grown as an organisation, in both membership and influence. This year our keynote event will for the first time take place over one and a half days, and include participants from across the Asia Pacific region. This represent a significant step forward, allowing for deeper discussion and therefore understanding of developments in our field; and for allowing helping facilitate cross-boarder and regional communication and collaboration.

We are delighted to again be able to welcome many distinguished and international guests to Hong Kong, and are grateful that they will be sharing with us their experience and expertise in both traditional and new therapies, and for giving us a glimpse of those in development.

We will hear how advances in the optimisation in patient selection criteria is allowing traditional treatments such as target therapy and chemotherapy to maximise gains in clinical outcomes; as well as how advances in understanding and technological application is creating a paradigm change in the way we can treat cancers through the use of increasingly sophisticated forms of immuno-therapy.

 

Meet our 2019 speakers
Prof. Bernard Escudier
Chair of the
Genitourinary Group
Institut Gustave Roussy, Villejuif
(France)
Prof. Oliver Sartor
Assistant Dean for Oncology
Tulane University School of Medicine
(USA)
Dr. Daniel Heng
Clinical Professor
Department of Oncology, Medical Oncology,
Tom Baker Cancer Centre
(Canada)
Prof. Alain Ravaud
Head of Department
of Medical Oncology,
Hôpital Saint André,
Bordeaux University Hospital, Bordeaux
(France)
Prof. Gerhardt Attard
John Black Charitable Foundation Endowed Chair for Urologic Research
University College London (UCL) Cancer Institute
(UK)
Prof. Michael S. Hofman
Professor
Sir Peter MacCallum Department of Oncology and Department of Medicine,
The University of Melbourne
(Australia)
Dr. Arjun Balar
Director
Genitourinary Medical Oncology Program,
Laura and Isaac Perlmutter Cancer Center,
NYU Langone Medical Center
(USA)
Dr. Ravindran Kanesvaran
Senior Consultant
Division of Medical Oncology,
National Cancer Centre Singapore
(Singapore)
Dr. Chee Keung Toh
Senior Consultant
Division of Medical Oncology
National Cancer Centre Singapore
Assistant Professor
Duke-NUS Medical School
(Singapore)
Dr. Min-Han Tan
Founder, Chief Executive Officer and Medical Director
Lucence Diagnostics Pte Ltd
(Singapore)
Dr. Garrett Ho
Department Head
Department of Nuclear Medicine & Positron Emission Tomography,
Hong Kong Sanatorium and Hospital
(Hong Kong)
Dr. Eddie Chan
Clinical Associate Professor
(Honorary)
The Chinese University of Hong Kong
(Hong Kong)
Dr. Darren Poon
Consultant,
Department of Clinical Oncology
Prince of Wales Hospital
(Hong Kong)
Dr. Angus Leung
Honorary Clinical Associate Professor
Department of Medicine and Therapeutics,
The Chinese University of Hong Kong
(Hong Kong)